VEMURAFENIB AS A SELECTIVE INHIBITOR OF THE SERINE THREONINE-PROTEIN KINASE B-RAF, USED IN THE TREATMENT OF MELANOMA. Prospect. Pharm. Sci. 2016, 14 (8), 52-56. https://doi.org/10.56782/pps.117.